UCLA radiation oncologists awarded $1.8M to advance personalized cancer therapy

Linda Liau elected to Taiwan’s Academia Sinica

Linda Liau, chair of neurosurgery at the David Geffen School of Medicine at UCLA, was elected as an Academician of Academia Sinica by the 35th Convocation of Academicians, the preeminent academic institution in Taiwan.

July 12, 2024

Vol.50 No.28

In Brief

Sanaz Memarzadeh receives $4.1M to develop immune therapies for ovarian cancer

Sanaz Memarzadeh of UCLA has received two grants totaling $4.1 million to develop advanced cell-based immune therapies for high-grade serous ovarian cancers that have become resistant to conventional treatments.

July 12, 2024

Vol.50 No.28

Drugs & Targets

FDA grants Fast Track designation to 225Ac-FL-020 radiopharmaceutical for mCRPC

FDA granted Fast Track designation for Ac-FL-020, a radiopharmaceutical which targets prostate-specific membrane antigen for the treatment of metastatic castration-resistant prostate cancer.xxx:more

July 12, 2024

Vol.50 No.28

In Brief

Marjan Boerma invested in J. Thomas May Distinguished Endowed Chair in Oncology at UAMS

The University of Arkansas for Medical Sciences College of Pharmacy invested Marjan Boerma, director of the UAMS College of Pharmacy Division of Radiation Health and associate director of basic science in the UAMS Winthrop P. Rockefeller Cancer Institute, in the J. Thomas May Distinguished Endowed Chair in Oncology in a June 25 ceremony.

July 05, 2024

Vol.50 No.27

In Brief

Vivek Kavadi named CEO of American Society for Radiation Oncology

Vivek S. Kavadi was named CEO of the American Society for Radiation Oncology. He will succeed Laura Thevenot, who has led the organization since 2002.

June 28, 2024

Vol.50 No.26

Clinical Roundup

Tai Chi reduces risk of inflammatory disease, treats insomnia among breast cancer survivors

Both Tai Chi and cognitive behavioral therapy can reduce insomnia in breast cancer survivors but also may provide additional health benefits by reducing inflammation and bolstering anti-viral defenses, according to a study led by UCLA Health researchers. The work was published in Brain, Behavior, and Immunity.

June 28, 2024

Vol.50 No.26

UCLA radiation oncologists awarded $1.8M to advance personalized cancer therapy

YOU MAY BE INTERESTED IN

Linda Liau elected to Taiwan’s Academia Sinica

Sanaz Memarzadeh receives $4.1M to develop immune therapies for ovarian cancer

FDA grants Fast Track designation to 225Ac-FL-020 radiopharmaceutical for mCRPC

Marjan Boerma invested in J. Thomas May Distinguished Endowed Chair in Oncology at UAMS

Vivek Kavadi named CEO of American Society for Radiation Oncology

Tai Chi reduces risk of inflammatory disease, treats insomnia among breast cancer survivors

Renew today!

Subscriber content

Login